Filing Details

Accession Number:
0001415889-25-015669
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-04 19:30:17
Reporting Period:
2025-06-02
Filing Date:
2025-06-04
Accepted Time:
2025-06-04 19:30:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1674632 Beta Bionics Inc. BBNX Surgical & Medical Instruments & Apparatus (3841) 475386878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2051384 Jon Steven Russell C/O Beta Bionics, Inc.
11 Hughes
Irvine CA 92618
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-06-02 285 $17.03 72,786 No 4 S Direct
Common Stock Disposition 2025-06-02 660 $18.15 72,126 No 4 S Direct
Common Stock Disposition 2025-06-02 94 $18.69 72,032 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  2. The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.